JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Aβ

A1123 Amyloid Beta-Peptide (12-28) (human)

Summary: sequence H2N-VHHQKLVFFAEDVGSNK-OH

≥195.5 mg/mL
A1124 Amyloid Beta-Peptide (1-40) (human)
1 Citation

Summary: Amyloid precursor protein

insoluble in EtOH; ≥23.8 mg/mL
A1002 Beta-Amyloid (1-11)

Summary: Amyloidogenic peptide

insoluble in EtOH; ≥132.5 mg/mL
A1003 Amyloid β-Protein (1-15)

Summary: Principal component of amyloid

insoluble in EtOH; ≥182.6 mg/mL
A1004 Amyloid Precursor C-Terminal Peptide

Summary: For beta amyloid generation

≥189.6 mg/mL
A1005 Beta-Sheet Breaker Peptide iAβ5

Summary: Peptide which can inhibit amyloidogenesis

≥63.7 mg/mL
A1026 β-Interleukin I (163-171), human

Summary: T cell activator

insoluble in EtOH; ≥100.4 mg/mL
A1027 β-Interleukin II (44-56)

Summary: Cytokine,regulating WBC

insoluble in EtOH; ≥150 mg/mL
A1053 amyloid A protein fragment [Homo sapiens]

Summary: Apolipoproteins related to HDL in plasma
A1038 Amyloid β-Peptide (10-20) (human)

Summary: Initiates neurodegeneration in Alzheimer disease

insoluble in EtOH; ≥144.7 mg/mL